文献速递其他结缔组织病系统性红斑狼疮

系统性硬化症患者中符合2019年EULAR/美国风湿病学会系统性红斑狼疮分类标准的患病率与特征

Prevalence and Characteristics of Patients With Systemic Sclerosis Fulfilling the 2019 EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2023-12-19

单中心回顾性研究分析402例系统性硬化症(SSc)患者,40例(10%)符合2019年EULAR/美国风湿病学会(ACR)SLE分类标准。SSc-SLE患者以女性、非裔美国人、局限性皮肤型SSc为主,抗U1-RNP抗体阳性率更高,但严重SSc特异器官损害和死亡率与单纯SSc患者相似。

要点

  • 402例SSc患者中40例(10%)符合2019年EULAR/ACR的SLE分类标准。
  • SSc-SLE患者抗U1-RNP抗体阳性率为30%,单纯SSc患者为6.6%(P < 0.001)。
  • 两组生存率无显著差异(log rank检验 P = 0.404)。

核心结论

  • 10%的SSc患者符合2019年EULAR/ACR的SLE分类标准,这些患者具有不同的人口学、血清学和临床表型,但严重SSc特异终末器官损害和死亡率与单纯SSc患者相似。
  • 作者认为,伴有雷诺现象的SLE患者应评估SSc特异性自身抗体和硬皮病器官受累。

研究设计与样本

  • 单中心、回顾性研究,纳入既往描述过的SSc队列中的402例患者,重新提取数据以评估是否符合2019年EULAR/ACR的SLE分类标准。
  • 比较SSc-SLE患者与单纯SSc患者的人口学、实验室、临床特征和死亡率。

主要发现

  • 402例SSc患者中40例(10%)符合2019年EULAR/ACR的SLE分类标准。
  • 神经精神和肾脏受累罕见。
  • 初始SLE诊断在SSc-SLE患者中占43%,在单纯SSc患者中占7%(P < 0.001)。
  • SSc-SLE患者更可能为女性、非裔美国人及局限性皮肤型SSc。
  • 抗U1-RNP抗体阳性率在SSc-SLE患者中为30%,在单纯SSc患者中为6.6%(P < 0.001)。

关键数值与推荐

  • 2019年EULAR/ACR的SLE分类标准用于定义SSc-SLE病例。
  • 抗U1-RNP抗体阳性率:SSc-SLE患者30% vs 单纯SSc患者6.6%(P < 0.001)。
  • 初始SLE诊断比例:SSc-SLE患者43% vs 单纯SSc患者7%(P < 0.001)。
  • 随访期间死亡比例:SSc-SLE患者30%(12例) vs 单纯SSc患者22%(81例),生存率log rank检验 P = 0.404。

临床怎么用

  • 作者认为,伴有雷诺现象的SLE患者应评估SSc特异性自身抗体和硬皮病器官受累。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is limited literature describing the overlap of systemic sclerosis (SSc) and systemic lupus erythematosus (SLE), and the studies have employed a range of case definitions. Our study used the new EULAR/American College of Rheumatology (ACR) SLE classification criteria to define SSc-SLE cases among our center's SSc cohort. METHODS: This is a single-center, retrospective study of a previously described cohort of patients with SSc. Patient data were re-abstracted to evaluate for fulfillment of the 2019 EULAR/ACR classification criteria for SLE. Demographic, laboratory, clinical features, and mortality were compared among patients with SSc-SLE and patients with SSc alone. RESULTS: Among the 402 patients with SSc that were analyzed, 40 (10%) fulfilled the 2019 EULAR/ACR SLE classification criteria. Neuropsychiatric and renal involvement were rare. An initial SLE diagnosis was purported in 43% of the patients with SSc-SLE and 7% of patients with SSc alone (P < 0.001). Patients with SSc-SLE were more likely to be female, African American, and with limited cutaneous SSc. Anti-U1-RNP antibody positivity prevalence was 30% among patients with SSc-SLE and 6.6% among patients with SSc alone (P < 0.001). Death during follow-up occurred in 12 patients (30%) with SSc-SLE and in 81 patients (22%) with SSc alone, but there was no difference in survival among the groups per log rank test (P = 0.404). CONCLUSION: Ten percent of patients with SSc fulfill the 2019 EULAR/ACR classification criteria for SLE. These patients comprise a distinct demographic, serologic, and clinical phenotype but have similar severe SSc-specific end-organ damage and mortality as patients with SSc alone. Patients with SLE with Raynaud phenomenon should be evaluated for SSc-specific autoantibodies and scleroderma organ involvement.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Bass RD, Moore DF, Steen VD, et al. Prevalence and Characteristics of Patients With Systemic Sclerosis Fulfilling the 2019 EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2023. PMID: 37691427. doi:10.1002/acr.25235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。